Jul.21 -- Novartis AG Chief Executive Officer Vasant Narasimhan discusses second-quarter earnings, efforts to find a Covid-19 vaccine, and growth prospects. He speaks on "Bloomberg Markets: European Open" after the Swiss drugmaker trimmed its sales forecast for the year as the coronavirus pandemic hit demand for the eye drug Lucentis and other medicines.
